Literature DB >> 6935977

Physostigmine in Tourette syndrome: evidence for cholinergic underactivity.

S M Stahl, P A Berger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6935977     DOI： 10.1176/ajp.138.2.240

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  7 in total

Review 1.  The biochemistry of Tourette's syndrome.

Authors:  P R Chokka; G B Baker; R A Bornstein; C M de Groot
Journal:  Metab Brain Dis       Date:  1995-06       Impact factor: 3.584

Review 2.  Gilles de la Tourette syndrome: a review.

Authors:  M Lawden
Journal:  J R Soc Med       Date:  1986-05       Impact factor: 5.344

3.  Coincidence of Tourette's disorder and infantile autism.

Authors:  G M Realmuto; B Main
Journal:  J Autism Dev Disord       Date:  1982-12

Review 4.  Tourette syndrome: a review and educational implications.

Authors:  A M Bauer; T M Shea
Journal:  J Autism Dev Disord       Date:  1984-03

Review 5.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

Review 7.  Merging the Pathophysiology and Pharmacotherapy of Tics.

Authors:  Farhan Augustine; Harvey S Singer
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-01-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.